These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 26332574)

  • 41. JUN mediates the senescence associated secretory phenotype and immune cell recruitment to prevent prostate cancer progression.
    Redmer T; Raigel M; Sternberg C; Ziegler R; Probst C; Lindner D; Aufinger A; Limberger T; Trachtova K; Kodajova P; Högler S; Schlederer M; Stoiber S; Oberhuber M; Bolis M; Neubauer HA; Miranda S; Tomberger M; Harbusch NS; Garces de Los Fayos Alonso I; Sternberg F; Moriggl R; Theurillat JP; Tichy B; Bystry V; Persson JL; Mathas S; Aberger F; Strobl B; Pospisilova S; Merkel O; Egger G; Lagger S; Kenner L
    Mol Cancer; 2024 May; 23(1):114. PubMed ID: 38811984
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Tissue inhibitor of metalloproteinases 3-dependent microvascular endothelial cell barrier function is disrupted under septic conditions.
    Arpino V; Mehta S; Wang L; Bird R; Rohan M; Pape C; Gill SE
    Am J Physiol Heart Circ Physiol; 2016 Jun; 310(11):H1455-67. PubMed ID: 26993226
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A human prostatic bacterial isolate alters the prostatic microenvironment and accelerates prostate cancer progression.
    Simons BW; Durham NM; Bruno TC; Grosso JF; Schaeffer AJ; Ross AE; Hurley PJ; Berman DM; Drake CG; Thumbikat P; Schaeffer EM
    J Pathol; 2015 Feb; 235(3):478-89. PubMed ID: 25348195
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Temporally controlled ablation of PTEN in adult mouse prostate epithelium generates a model of invasive prostatic adenocarcinoma.
    Ratnacaram CK; Teletin M; Jiang M; Meng X; Chambon P; Metzger D
    Proc Natl Acad Sci U S A; 2008 Feb; 105(7):2521-6. PubMed ID: 18268330
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Liver X receptors constrain tumor development and metastasis dissemination in PTEN-deficient prostate cancer.
    Alioui A; Dufour J; Leoni V; Loregger A; Moeton M; Iuliano L; Zerbinati C; Septier A; Val P; Fouache A; Russo V; Volle DH; Lobaccaro JA; Zelcer N; Baron S
    Nat Commun; 2017 Sep; 8(1):445. PubMed ID: 28874658
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Notch promotes tumor metastasis in a prostate-specific Pten-null mouse model.
    Kwon OJ; Zhang L; Wang J; Su Q; Feng Q; Zhang XH; Mani SA; Paulter R; Creighton CJ; Ittmann MM; Xin L
    J Clin Invest; 2016 Jul; 126(7):2626-41. PubMed ID: 27294523
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The MDA-9/Syntenin/IGF1R/STAT3 Axis Directs Prostate Cancer Invasion.
    Das SK; Pradhan AK; Bhoopathi P; Talukdar S; Shen XN; Sarkar D; Emdad L; Fisher PB
    Cancer Res; 2018 Jun; 78(11):2852-2863. PubMed ID: 29572229
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Characterization of Heterogeneous Prostate Tumors in Targeted Pten Knockout Mice.
    Korsten H; Ziel-van der Made AC; van Weerden WM; van der Kwast T; Trapman J; Van Duijn PW
    PLoS One; 2016; 11(1):e0147500. PubMed ID: 26807730
    [TBL] [Abstract][Full Text] [Related]  

  • 49. TET1 suppresses cancer invasion by activating the tissue inhibitors of metalloproteinases.
    Hsu CH; Peng KL; Kang ML; Chen YR; Yang YC; Tsai CH; Chu CS; Jeng YM; Chen YT; Lin FM; Huang HD; Lu YY; Teng YC; Lin ST; Lin RK; Tang FM; Lee SB; Hsu HM; Yu JC; Hsiao PW; Juan LJ
    Cell Rep; 2012 Sep; 2(3):568-79. PubMed ID: 22999938
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Interleukin-6 and oncostatin-M synergize with the PI3K/AKT pathway to promote aggressive prostate malignancy in mouse and human tissues.
    Smith DA; Kiba A; Zong Y; Witte ON
    Mol Cancer Res; 2013 Oct; 11(10):1159-65. PubMed ID: 23867565
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The Angiogenic Effect of microRNA-21 Targeting TIMP3 through the Regulation of MMP2 and MMP9.
    Hu J; Ni S; Cao Y; Zhang T; Wu T; Yin X; Lang Y; Lu H
    PLoS One; 2016; 11(2):e0149537. PubMed ID: 26872030
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Multiple cellular mechanisms related to cyclin A1 in prostate cancer invasion and metastasis.
    Wegiel B; Bjartell A; Tuomela J; Dizeyi N; Tinzl M; Helczynski L; Nilsson E; Otterbein LE; Härkönen P; Persson JL
    J Natl Cancer Inst; 2008 Jul; 100(14):1022-36. PubMed ID: 18612129
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Tissue inhibitor of metalloproteinase-3 (TIMP3) promotes endothelial apoptosis via a caspase-independent mechanism.
    Qi JH; Anand-Apte B
    Apoptosis; 2015 Apr; 20(4):523-34. PubMed ID: 25558000
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Tpl2 knockout keratinocytes have increased biomarkers for invasion and metastasis.
    Decicco-Skinner KL; Jung SA; Tabib T; Gwilliam JC; Alexander H; Goodheart SE; Merchant AS; Shan M; Garber C; Wiest JS
    Carcinogenesis; 2013 Dec; 34(12):2789-98. PubMed ID: 24067898
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Tissue inhibitor of metalloproteinase-3 (TIMP3) expression decreases during melanoma progression and inhibits melanoma cell migration.
    Das AM; Bolkestein M; van der Klok T; Oude Ophuis CM; Vermeulen CE; Rens JA; Dinjens WN; Atmodimedjo PN; Verhoef C; Koljenović S; Smits R; Ten Hagen TL; Eggermont AM
    Eur J Cancer; 2016 Oct; 66():34-46. PubMed ID: 27522248
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effects of TRPC6 on invasibility of low-differentiated prostate cancer cells.
    Wang D; Li X; Liu J; Li J; Li LJ; Qiu MX
    Asian Pac J Trop Med; 2014 Jan; 7(1):44-7. PubMed ID: 24418082
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prostate-Specific G-Protein Coupled Receptor, an Emerging Biomarker Regulating Inflammation and Prostate Cancer Invasion.
    Rodriguez M; Siwko S; Liu M
    Curr Mol Med; 2016; 16(6):526-32. PubMed ID: 27280498
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Both mature miR-17-5p and passenger strand miR-17-3p target TIMP3 and induce prostate tumor growth and invasion.
    Yang X; Du WW; Li H; Liu F; Khorshidi A; Rutnam ZJ; Yang BB
    Nucleic Acids Res; 2013 Nov; 41(21):9688-704. PubMed ID: 23990326
    [TBL] [Abstract][Full Text] [Related]  

  • 59. DGCR8 is essential for tumor progression following PTEN loss in the prostate.
    Belair CD; Paikari A; Moltzahn F; Shenoy A; Yau C; Dall'Era M; Simko J; Benz C; Blelloch R
    EMBO Rep; 2015 Sep; 16(9):1219-32. PubMed ID: 26206718
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Tissue inhibitor of metalloproteinase 3 deficiency causes hepatic steatosis and adipose tissue inflammation in mice.
    Menghini R; Menini S; Amoruso R; Fiorentino L; Casagrande V; Marzano V; Tornei F; Bertucci P; Iacobini C; Serino M; Porzio O; Hribal ML; Folli F; Khokha R; Urbani A; Lauro R; Pugliese G; Federici M
    Gastroenterology; 2009 Feb; 136(2):663-72.e4. PubMed ID: 19027012
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.